No. of items: 226
Sorting after results
05/11/2019
Morphosys: from “protein optimization” to pharmaceuticals
The German biotechnology company Morphosys has made another stride towards marketing tafasitamab – its drug for treating B-cell malignancies such as non-Hodgkin’s lymphoma – in the US. At the end of October, the Munich-based company announced that the Real World Data Study had shown that tafasitamab …
24/10/2019
MEDICA provides insights on and opens doors to German healthcare market
Market experts from Germany Trade & Invest and the export initiative for the German healthcare industry, HEALTH MADE IN GERMANY, are ready for MEDICA. They will be at the world’s leading medical trade fair to, among other things, inform guests from abroad about the latest in Germany’s healthcare …
25/09/2019
"German Pavilion" premiers at Pharmed & Healthcare Vietnam
German healthcare companies have taken part in the premiere appearance of the German Pavilion at Pharmed & Healthcare Vietnam, the Southeast Asian country's leading trade show for medtech and medicine. The shared stand is all about showing what sets products "made in Germany" apart from the rest in …
17/09/2019
Germany takes lead in testing innovative antibacterial implant coating
The Berlin-based medical device company aap Implantate AG (app) is becoming the first company in the world to conduct human clinical trials for an antibacterial silver coating on anatomical plates for treating broken bones. In August, Germany's Federal Institute for Drugs and Medical Devices (BfArM) …
11/09/2019
CureVac financing research at Yale to advance drug development
The German biopharmaceuticals company CureVac has signed a collaborative research agreement (CRA) with Yale University to discover new, candidate drugs for treating lung diseases. The Tübingen-based company is financing the entire research project and retains an option to acquire any rights …
03/09/2019
Major German project addresses challenges of digitizing patient data
Six of Germany's Helmholtz centers are cooperating to ensure patient privacy is protected while allowing science to use patient data to advance innovative medicine. They have set up the Helmholtz Medical Security, Privacy, and AI Research Center (HMSP) to pursue this aim.
28/08/2019
German program to further the use of artificial intelligence (AI) in medicine
The German government is pursuing the development of medical uses of AI. At a panel discussion held in conjunction with the country's Science Year 2019 (Wissenschaftsjahr 2019) Germany's Minister of Education and Research, Anja Karliczek, and a group of experts spoke about how to lay the groundwork …
20/08/2019
Germany supplies implant materials for HIV preventive prototype
The multinational pharmaceutical company Merck Sharp & Dohme (MSD) has developed an implantable product capable of delivering a drug that provides protection from infection with HIV for one year. The matchstick-sized implant releases the antiretroviral drug islatravir, formerly called EFdA or …
14/08/2019
German medical biotechnology in the spotlight
Germany's medical biotechnology sector is one of the most dynamic in the world. A new video from Germany Trade and Invest (GTAI) and the Export Initiative for the German Healthcare Industry, HEALTH MADE IN GERMANY, provides insight and facts & figures on this innovative, growing field.
06/08/2019
Thriving German medtech ready for medical revolution
The association that represents Germany's medical technology companies, BVMed, is predicting that the medtech sector will continue growing. It cites experts forecasting an annual growth rate of four to five percent. This is according to the BVMed Annual Report 2018/19, which is based on a survey of …
- Recommend this page:
- Print view